| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |